RX Drugnews homepage



  • Ultralytic 2 Cream 20% (Ivax Dermatologicals)

    For external use only. Not for ophthalmic use.

    DESCRIPTION

    Ultralytic™ 2 Cream contains 20% urea in a topical cosmetic vehicle containing 12% ammonium lactate.

    Ultralytic™ 2 Cream is a keratolytic emollient moisturizer. Each gram contains 20% urea, purified water, ammonium lactate, white petrolatum, octyl palmitate, cetyl alcohol, caprylic/capric triglyceride, hydrogenated polyisobutene, glycerin, glyceryl stearate & PEG-100 stearate, rice starch, cetearyl alcohol and cetearyl glucoside, phenoxyethanol, dimethicone, potassium sorbate, allantoin, xanthan gum, tocopheryl acetate.

    Urea is a diamide of carbonic acid with the following chemical structure:


    CLINICAL PHARMACOLOGY

    Urea gently lyses/dissolves the intercellular matrix of surface skin cells loosening and allowing a shedding of rough, thickened and scaly hyperkeratotic skin. Urea also moisturizes and softens skin.

    PHARMACOKINETICS:    The mechanisms of action of topically applied Urea are not yet known.

    INDICATIONS AND USES

    For softening, smoothing and removing rough scaling hyperkeratotic skin in conditions such as xerosis, ichthyosis, skin cracks and fissures, dermatitis, eczema, psoriasis, keratoses and calluses.

    CONTRAINDICATIONS

    Known hypersensitivity to any of the listed ingredients. Discontinue if hypersensitivity is observed. Sun exposure to areas of skin treated with Ultralytic™ 2 Cream should be minimized or avoided.

    WARNINGS

    For external use only. Avoid contact with eyes, lips or mucous membranes.

    PRECAUTIONS

    Information for Patients:    This medication is to be used as directed by a physician and should not be used to treat any condition other than that for which it was prescribed. If redness or irritation occurs, discontinue use.

    PREGNANCY:    Pregnancy Category C. Animal reproduction studies have not been conducted with Ultralytic™ 2 Cream . It is also not known whether Ultralytic™ 2 Cream can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Ultralytic™ 2 Cream should be given to a pregnant woman only if clearly needed.

    NURSING MOTHERS:    It is not known whether or not this drug is secreted in human milk. Because many drugs are secreted in human milk, caution should be exercised when Ultralytic™ 2 Cream is administered to a nursing woman.

    ADVERSE REACTIONS

    Transient stinging, burning, itching or irritation may occur and normally disappear on discontinuing the medication.

    DOSAGE AND ADMINISTRATION

    Apply Ultralytic™ 2 Cream to affected skin twice per day, or as directed by a physician. Rub in until completely absorbed.

    HOW SUPPLIED

    Ultralytic™ 2 Cream 20% is supplied in a 113 g (4oz.) tube.

    NDC 13613-230-04

    Store at room temperature 15°-25°C (59°-77° F).

    Protect from freezing.

    Mfg. Exclusively

    for: Ivax Dermatologicals, Inc.
    4400 Biscayne Blvd.
    Miami, FL 33137
    Mfg. by: Clay-Park Labs, Inc.
    Bronx, NY 10452

    05/05


Subscribe to the "News" RSS Feed RSS

  ۞



 

About Us   |  Privacy Policy   |  Terms of Use   |  Contact Us  

© 2012 RxDrug News 1999-2016. All rights reserved